Immunocytochemical Characterization of Alzheimer’s Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine. This evidence concerns the gene PSEN1 and early-onset autosomal dominant Alzheimer disease.